JACC Podcast

American College of Cardiology
  • 0.0 (0)
  • MEDIZIN
  • TÄGLICH
Podcast JACC Podcast

Each week, renowned editor-in-chief of the Journal of the American College of Cardiology (JACC), Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition, as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.

  1. VOR 4 TAGEN

    Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care

    In this episode, Dr. Valentin Fuster reviews a groundbreaking study comparing metabolic surgery to traditional care for patients with obesity and obstructive sleep apnea. The research shows that metabolic surgery significantly lowers the risk of major cardiovascular events and mortality, highlighting the need for a multifaceted approach to treating these interlinked conditions.

    12 Min.

  2. VOR 4 TAGEN

    Effect of Evogliptin on the Progression of Aortic Valvular Calcification

    In the September 17, 2024 issue of JACC, Dr. Jai Quan Song and colleagues explore whether the DPP-4 inhibitor, abrogating, can slow the progression of aortic valvular calcification. Although the primary endpoint was not met, the study's promising secondary results and ongoing research into related therapies suggest potential future breakthroughs in medical treatment for aortic stenosis.

    11 Min.

  3. VOR 4 TAGEN

    Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF

    In the September 17, 2024 issue of JACC, Valentin Fuster discusses a study on sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, which shows modest improvements in health status among patients with worsening heart failure. While the study highlights sotagliflozin's benefits, it also points out gaps in understanding its full impact and emphasizes the need to optimize current treatments and explore future interventions.

    11 Min.

  4. VOR 4 TAGEN

    Genotype Guided Antiplatelet Therapy: JACC Review Topic of the Week

    In this episode of JACC, Valentin Fuster examines genotype-guided antiplatelet therapy, emphasizing its potential to tailor treatments based on genetic variants for improved patient outcomes. While promising, the approach faces challenges like testing delays and variable patient responses that need addressing for broader implementation.

    12 Min.

  5. VOR 4 TAGEN

    JACC - September 17, 2024 Issue Summary

    In this episode, Valentin Fuster reviews the September 17, 2024, JACC issue, highlighting pivotal studies on metabolic surgery's impact on cardiovascular risk in obstructive sleep apnea patients, and the potential of DPP-4 inhibitors in aortic valve calcification. He also discusses the benefits of Sitagliptin for heart failure and the prognostic value of plasma immunoglobulins in pulmonary arterial hypertension, closing with a look at genotype-guided antiplatelet therapy.

    23 Min.

  6. VOR 4 TAGEN

    Prognostic value of plasma IgG N-glycome traits in pulmonary arterial hypertension

    In this September 17, 2024 JACC issue, Dr. Zhi Jian Zhang and colleagues unveil a groundbreaking study on pulmonary arterial hypertension (PAH) that identifies plasma IgG fucosylation and glycan traits as promising prognostic markers. This research not only enhances survival predictions beyond current models but also opens intriguing possibilities for future therapeutic targets in PAH.

    11 Min.

  7. 6. SEPT.

    RESHAPE-HF2 Trial Findings | ESC 2024

    Dr. Marcus Anker, presenting at ESC, discussed the RESHAPE HF2 trial's findings on transcatheter edge-to-edge repair for secondary mitral regurgitation, published in JACC with Aakriti Gupta, MD, FACC, JACC Executive Associate Editor.

    6 Min.

  8. 5. SEPT.

    Effect of Screening for Undiagnosed Atrial Fibrillation and on Stroke Prevention | ESC Congress

    Xiaoxi Yao, MPH, MS, PhD, FACC, JACC Associate Editor, interviews Renato Lopes, MD, PhD, FACC, author of the GUARD-AF trial published in JACC and presented at ESC Congress 2024.

    14 Min.
Alle anzeigen (765)

Info

Each week, renowned editor-in-chief of the Journal of the American College of Cardiology (JACC), Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition, as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.

Informationen

  • Erstellt von
    American College of Cardiology
  • Jahre aktiv
    2014 - 2024
  • Folgen
    765
  • Bewertung
    Unbedenklich
  • Copyright
    © American College of Cardiology Foundation. All rights reserved.
  • Sendungswebsite
    JACC Podcast

Das gefällt dir vielleicht auch

Melde dich an, um anstößige Folgen anzuhören.

Bleib auf dem Laufenden mit dieser Sendung

Melde dich an oder registriere dich, um Sendungen zu folgen, Folgen zu sichern und die neusten Updates zu erhalten.
Wähle ein Land oder eine Region aus

Afrika, Naher Osten und Indien

Asien/Pazifik

Europa

Lateinamerika und Karibik

USA und Kanada